Science Applications International Corp Income Taxes Disclosure
| Year Ended | |||||||||||||||||
| January 30, 2026 | January 31, 2025 | February 2, 2024 | |||||||||||||||
| (in millions) | |||||||||||||||||
| Current: | |||||||||||||||||
| Federal | $ | (64) | $ | 56 | $ | 125 | |||||||||||
| State | 11 | 13 | 35 | ||||||||||||||
Foreign | 1 | — | — | ||||||||||||||
| Deferred: | |||||||||||||||||
| Federal | 82 | (4) | (19) | ||||||||||||||
| State | (1) | 1 | 2 | ||||||||||||||
| Total | $ | 29 | $ | 66 | $ | 143 | |||||||||||
Year Ended | ||||||||
| January 30, 2026 | ||||||||
Amount | Percent | |||||||
(dollars in millions) | ||||||||
Amount computed at the statutory federal income tax rate | $ | 81 | 21.0 | % | ||||
State income taxes, net of federal income tax effect(1) | 13 | 3.4 | % | |||||
Tax credits | ||||||||
Research and development credits | (10) | (2.5) | % | |||||
Other credits | (1) | (0.4) | % | |||||
Non-taxable or non-deductible items | ||||||||
Non-deductible compensation | 7 | 1.7 | % | |||||
Other | (1) | (0.2) | % | |||||
Changes in unrecognized tax benefits | (57) | (14.8) | % | |||||
Other | (3) | (0.7) | % | |||||
Effective income tax rate | $ | 29 | 7.5 | % | ||||
Year Ended | |||||||||||
| January 31, 2025 | February 2, 2024 | ||||||||||
(dollars in millions) | |||||||||||
| Amount computed at the statutory federal income tax rate | $ | 90 | $ | 130 | |||||||
| State income taxes, net of federal tax benefit | 10 | 32 | |||||||||
| Research and development and other federal credits | (22) | (17) | |||||||||
| Non-deductible compensation | 3 | 10 | |||||||||
| Excess tax benefits for stock-based compensation | (4) | (4) | |||||||||
| Non-deductible goodwill | — | 13 | |||||||||
| Foreign-derived intangible income | (15) | (22) | |||||||||
| Other | 4 | 1 | |||||||||
| Total | $ | 66 | $ | 143 | |||||||
| Effective income tax rate | 15.5 | % | 23.1 | % | |||||||
| Year Ended | |||||
| January 30, 2026 | |||||
| (in millions) | |||||
U.S. Federal | $ | 10 | |||
U.S. State and Local | |||||
California | 4 | ||||
Texas | 2 | ||||
| Virginia | 3 | ||||
| Other | 2 | ||||
Foreign | 1 | ||||
| Total cash paid for income taxes, net of refunds | $ | 22 | |||
| January 30, 2026 | January 31, 2025 | ||||||||||
| (in millions) | |||||||||||
| Accrued vacation and bonuses | $ | 25 | $ | 27 | |||||||
| Deferred compensation | 20 | 20 | |||||||||
| Net operating loss and other carryforwards | 155 | 61 | |||||||||
| Lease liability | 55 | 48 | |||||||||
| Research and development expenditures | 21 | 197 | |||||||||
Other | 15 | 20 | |||||||||
| Valuation allowance | (7) | (7) | |||||||||
| Total deferred tax assets | 284 | 366 | |||||||||
| Deferred revenue | (31) | (40) | |||||||||
| Purchased intangible assets | (297) | (302) | |||||||||
| Right of use assets | (48) | (41) | |||||||||
Other | (12) | (7) | |||||||||
| Total deferred tax liabilities | (388) | (390) | |||||||||
| Net deferred tax (liabilities) assets | $ | (104) | $ | (24) | |||||||
| Year Ended | |||||||||||||||||
| January 30, 2026 | January 31, 2025 | February 2, 2024 | |||||||||||||||
| (in millions) | |||||||||||||||||
| Unrecognized tax benefits at beginning of the year | $ | 110 | $ | 117 | $ | 158 | |||||||||||
| Additions for tax positions related to prior years | 2 | 1 | 5 | ||||||||||||||
| Additions for tax positions related to the current year | 6 | 14 | 21 | ||||||||||||||
| Reductions for tax positions related to prior years | (46) | (8) | (59) | ||||||||||||||
Reductions for settlements with taxing authorities | (19) | — | — | ||||||||||||||
| Reductions for prior year tax positions related to statute expiration | (5) | (14) | (8) | ||||||||||||||
| Unrecognized tax benefits at end of the year, excluding accrued interest and penalties | $ | 48 | $ | 110 | $ | 117 | |||||||||||
| Unrecognized tax benefits that, if recognized, would affect the effective income tax rate | $ | 43 | $ | 104 | $ | 111 | |||||||||||
| Accrued interest and penalties | $ | 7 | $ | 17 | $ | 13 | |||||||||||
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2026 | Mar 16, 2026 | Showing above |
| 2025 | Mar 17, 2025 | |
| 2024 | Mar 20, 2024 | |
| 2023 | Apr 3, 2023 | |
| 2022 | Mar 28, 2022 | |
| 2021 | Mar 26, 2021 | |
| 2020 | Mar 27, 2020 | |
| 2019 | Mar 29, 2019 | |
| 2018 | Mar 29, 2018 | |
| 2017 | Mar 30, 2017 | |
| 2016 | Mar 29, 2016 | |
About Income Taxes Disclosures
The income tax disclosure reveals how much a company actually pays in taxes versus what the statutory rate would predict. Analysts focus on the effective tax rate (ETR) reconciliation, which breaks down every item driving the gap between the 21% federal rate and the company's reported ETR — including R&D credits, foreign rate differentials, and state taxes. Deferred tax assets (DTAs) and their valuation allowances signal management's confidence in future profitability: a rising allowance suggests the company doubts it can use accumulated tax benefits. Uncertain tax benefit (UTB) reserves quantify exposure to IRS challenges on aggressive positions.
Key signals to watch: sudden ETR drops without clear operational reasons, large increases in valuation allowances, growing UTB balances, and significant unremitted foreign earnings. Post-TCJA, pay attention to GILTI and BEAT provisions that affect multinational tax structures. Compare the cash taxes paid (from the cash flow statement) against the income tax provision to gauge earnings quality.